AVR
NASDAQ · Health Care
Anteris Technologies Global
$9.67
-0.18 (-1.83%)
Financial Highlights (FY 2026)
Revenue
5.34M
Net Income
-262,905,671
Gross Margin
70.3%
Profit Margin
-4,921.3%
Rev Growth
-15.8%
D/E Ratio
—
Revenue & Net Income
Margin Trends
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Gross Margin | 70.3% | 70.3% | 49.0% | 49.0% |
| Operating Margin | -4,908.2% | -4,417.4% | 22.4% | 18.5% |
| Profit Margin | -4,921.3% | -4,675.2% | 15.0% | 17.3% |
Income Statement
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Revenue | 5.34M | 6.34M | 55.67M | 50.34M |
| Gross Profit | 3.75M | 4.45M | 27.28M | 24.67M |
| Operating Income | -262,076,130 | -280,029,107 | 12.47M | 9.31M |
| Net Income | -262,905,671 | -280,915,474 | 8.34M | 8.70M |
| Gross Margin | 70.3% | 70.3% | 49.0% | 49.0% |
| Operating Margin | -4,908.2% | -4,417.4% | 22.4% | 18.5% |
| Profit Margin | -4,921.3% | -4,675.2% | 15.0% | 17.3% |
| Rev Growth | -15.8% | -15.8% | +16.7% | +18.7% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Total Debt | 0 | 0 | 58.12M | 59.46M |
| Total Equity | — | — | 133.98M | 123.04M |
| D/E Ratio | — | — | 0.43 | 0.48 |
Cash Flow
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| EBITDA | -257,576,433 | -290,511,232 | 15.39M | 14.55M |
| Free Cash Flow | — | — | 6.68M | 6.27M |